Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.94
Bid: 12.96
Ask: 13.04
Change: -1.84 (-12.45%)
Spread: 0.08 (0.617%)
Open: 14.60
High: 14.60
Low: 12.86
Prev. Close: 14.78
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full year results update

25 Mar 2020 14:57

RNS Number : 6032H
EnQuest PLC
25 March 2020
 

 

EnQuest PLC, 25 March 2020

Financial Conduct Authority ('FCA') and Financial Reporting Council ('FRC') moratorium on publication of results

 

On 21 March 2020, the FCA issued a strong request to all London listed companies to observe a moratorium on the publication of financial statements for a minimum of two weeks, due to the unprecedented global outbreak of coronavirus ('COVID-19'). On 23 March 2020, the FRC issued an announcement requesting companies and their auditors delay other corporate reports, such as final audited financial statements.

In accordance with the these requests, EnQuest PLC will postpone publishing its 2019 Annual Results, for the twelve months ended 31 December 2019. The Company will announce the date for the publication of its 2019 results in due course.

For more information on the FCA and FRC requests, please visit: https://www.fca.org.uk/news/statements/fca-requests-delay-forthcoming-announcement-preliminary-financial-accounts or https://www.frc.org.uk/news/march-2020-(1)/frc-supports-moratorium-in-corporate-reporting.

Ends

For further information, please contact:

 

EnQuest PLC

Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

 

Jonathan Swinney (Chief Financial Officer)

 

Ian Wood (Head of Communications & Investor Relations)

 

Jonathan Edwards (Senior Investor Relations & Communications Manager)

 

 

 

Tulchan Communications

Tel: +44 (0)20 7353 4200

Martin Robinson

 

Martin Pengelley

 

Harry Cameron

 

 

Notes to editors

ENQUEST

EnQuest is an independent production and development company with operations in the UK North Sea and Malaysia. The Group's strategic vision is to be the operator of choice for maturing and underdeveloped hydrocarbon assets, by focusing on operational excellence, differential capability, value enhancement and financial discipline.

EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm. Its UK operated assets include Thistle/Deveron, Heather/Broom, the Dons area, Magnus, the Greater Kittiwake Area, Scolty/Crathes Alma/Galia and Kraken; EnQuest also has an interest in the non-operated Alba producing oil field. At the end of December 2019, EnQuest had interests in 17 UK production licences and was the operator of 15 of these licences. EnQuest's interests in Malaysia include the PM8/Seligi and PM409 Production Sharing Contracts, both of which the Group operates.

Forward-looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectations and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this announcement should be construed as a profit forecast. Past share price performance cannot be relied upon as a guide to future performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORKZGZFDKMGGZM
Date   Source Headline
16th Jul 201212:24 pmRNSResult of EGM
28th Jun 20124:59 pmRNSEnQuest Circular and EGM Notice
15th Jun 20125:12 pmRNSDirector/PDMR Shareholding
13th Jun 20128:55 amRNSDirector/PDMR Shareholding
1st Jun 20129:52 amRNSDirector/PDMR Shareholding
30th May 20124:29 pmRNSDirectorate Change
30th May 20123:56 pmRNSAGM Statement
29th May 20123:30 pmRNSEnQuest to farm out approx. £300m of Alma/Galia
18th May 20127:00 amRNSInterim Management Statement
14th May 201210:28 amRNSDirector/PDMR Shareholding
26th Apr 20127:00 amRNSProposed acquisition of a third tranche of Kraken
25th Apr 20124:48 pmRNSAnnual Financial Report
20th Apr 20129:30 amRNSDirector/PDMR Shareholding
27th Mar 20127:00 amRNSFinal Results
16th Mar 20127:00 amRNSEnQuest completes acquisition of 25% of Kraken
3rd Feb 201211:06 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Feb 201210:18 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
31st Jan 20124:44 pmRNSEnQuest completes acquisition of 20% of Kraken
26th Jan 201210:56 amRNSDirector/PDMR Shareholding
25th Jan 201210:38 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
24th Jan 20127:30 amRNSSale of 25% of Kraken to EnQuest PLC
24th Jan 20127:30 amRNSEnQuest acquires a further 25% of Kraken
10th Jan 20129:52 amRNSChange of Director's Details
9th Jan 20127:00 amRNSEnQuest acquires 20% of Kraken Discovery
3rd Jan 201212:44 pmRNSDirector/PDMR Shareholding
28th Dec 201112:09 pmRNSDirector/PDMR Shareholding
19th Dec 201111:36 amRNSDirector/PDMR Shareholding
30th Nov 20112:30 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSEnQuest sanctions development of Alma and Galia
16th Nov 20117:00 amRNSInterim Management Statement
7th Nov 201110:53 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
30th Sep 201112:08 pmRNSDirector/PDMR Shareholding
28th Sep 201112:13 pmRNSDirector/PDMR Shareholding
6th Sep 20119:49 amRNSDirector/PDMR Shareholding
2nd Sep 20114:47 pmRNSProduction and Development Update
2nd Sep 201110:22 amRNSDirector/PDMR Shareholding
24th Aug 201112:32 pmRNSCorrection - Director/PDMR Shareholding
24th Aug 201111:37 amRNSDirector/PDMR Shareholding
12th Aug 20117:00 amRNSHalf Yearly Report
22nd Jul 201111:39 amRNSNotice of Results
1st Jul 201112:18 pmRNSDirector/PDMR Shareholding
30th Jun 20113:17 pmRNSEnQuest Completes Acquisition
14th Jun 201112:55 pmRNSAppointment of Non-Executive Director
14th Jun 201111:15 amRNSNotification of Major Interest in Shares
9th Jun 20115:32 pmRNSDirector/PDMR Shareholding
31st May 201110:00 amRNSDirector/PDMR Shareholding
25th May 20113:24 pmRNSAGM Results
25th May 20113:21 pmRNSDirectorate Change
18th May 20117:00 amRNSInterim Management Statement
10th May 20117:00 amRNSEnQuest to acquire stake in Crawford & Porter Dev

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.